glp 1 and heart disease Mechanisms of GLP-1 Receptor Agonists in HFpEF: Exploring Weight-Dependent Independent Drivers of Therapeutic Benefit GLP-1 and the cardiovascular system

Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients

These FDA-approved treatments help regulate appetite, improve blood sugar control, and support sustainable weight loss

The bloating is often worse in the evening

Were seeing a lot of efficacy with the GLP-1 receptor agonists, but how can we make them even better? asks Professor Bethany Cummings, who conducts metabolic research at UC Davis, California

Patient safety is our top priority at Novo Nordisk

Consult a health care practitioner prior to use if you are pregnant or breastfeeding, or if you have a liver disease or diabetes